1 / 71

LOCAL ANESTHESIA presented by deepti awasthi

LOCAL ANESTHESIA presented by deepti awasthi. CONTENTS. Introduction Definitions History Ideal Properties of LA Mechanism Of Action Classification Constituents Pharmacokinetics- Uptake , distribution, Metabolism , excretion. Vasoconstrictors

caesar
Download Presentation

LOCAL ANESTHESIA presented by deepti awasthi

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. LOCAL ANESTHESIA presented by deeptiawasthi

  2. CONTENTS • Introduction • Definitions • History • Ideal Properties of LA • Mechanism Of Action • Classification • Constituents • Pharmacokinetics- Uptake , distribution, Metabolism , excretion • Vasoconstrictors • Local anesthetic agents • Topical anesthetics • Complication • Recent advances. • In pediatric dentistry • References

  3. INTRODUCTION

  4. DEFINITIONS • Acc to Malamed 1980 : Loss of sensation in a circumscribed area of the body caused by depression of excitation in nerve endings and inhibition of the conduction process in peripheral nerves

  5. Reversible loss of sensation in a body part without the loss of consciousness or the impairment of central control of vital functions. • Damle

  6. HISTORY • 1860 – Albert Nieman was first to isolate cocaine & discovered its anesthetic properties • 1884 – Karl Koller used cocaine as a topical anesthetic for opthalmological surgical procedures. • 1905 – Alfred Einhorm developed procaine, • 1943 – Lidocaine by Lofgren • Damle

  7. IDEAL PROPERTIES OF LA

  8. Desirable properties by Bennett

  9. MECHANISM OF ACTION

  10. CLASSIFICATION ESTERS Of benzoic acid • Cocaine • Butacaine • Piperocaine • Tetracaine • Ethyl amino benzoate (benzocaine) • hexylcaine Of p-aminobenzoic acid • Procaine • Chlorprocaine • propoxycaine

  11. AMIDES • Articaine • Bupivacaine • Dibucaine • Etidocaine • Lidocaine • Mepivacaine • Prilocaine • Ropivacaine QUINOLINE • Centbucridine

  12. Based on duration of action : • Long acting ( 90 + mins ) • Bupivacaine + epinephrine • Etidocaine • Intermediate acting ( 60 mins ) • Articaine + epinephrine • Lidocaine + epinephrine • Mepivacaine + epinephrine • Short acting (30 mins) • Lidocaine • Mepivacaine • Prilocaine Malamed

  13. CONSTITUENTS • Local anesthetic agents • Vasoconstrictors purpose served : • Decreased blood flow to the site • Absorption of LA into the CVS is slowed. • Decreases the risk of LA toxicity. • Increased duration of action

  14. 3. Reducing agents : To minimize oxidation of vasoconstrictor - sodium metabisulphite 4. Preservative : methyl paraben if allergic- caprylhydrocuprinotoxin. 5. Fungicide : thymol 6. Vehicle : modified ringer’s soln isotonic vehicle minimizes discomfort during injection. S.Tandon

  15. PHARMACOKINETICS

  16. UPTAKE : All LA produces vasodilation, cocaine – only LA producing vasoconstriction. Oral : absorbed poorly from GIT(except cocaine) Topical : absorbed at diff rates I.V. : primary management of ventricular dysrythmia.

  17. DISTRIBUTION – Highly perfused organs have higher level. skeletal muscle – greatest % of LA The blood level is influenced by factors : • Rate of absorption into CVS. • Rate of distribution to the tissues. • Elimination of the drug. Crosses BBB

  18. METABOLISM Overall toxicity depends upon balance b/w rate of absorption & removal from blood. ESTER : hydrolysed in the plasma by pseudocholinesterase ( Kalow W : hydrolysis of LA by human serum cholinesterase, J Pharmacol exp ther 104: 122-134, 1952)

  19. Chlorprocaine , most rapidly hydrolysed • Tetracaine , 16 times slowly hydrolysed • Procaine undergoes hydrolysis to PABA ,

  20. AMIDE : primary site of biotransformation is Liver. • Prilocaine – some also in the lung. • 70% of a dose of injected lidocaine undergoes biotransformation in patient with normal liver function.

  21. EXCRETION : Kidneys – primary excretory organ Esters : appear in very small conc as parent compound in urine Amides : higher % Malamed

  22. VASOCONSTRICTORS • DIRECT ACTING : • Epinephrine • Norepinephrine • Levonordefrin • Isoproteronol • Dopamine • Methoxamine • phenylephrine

  23. INDIRECT ACTING : • Tyramine • Amphetamine • Methamphetamine • Hydroxyamphetamine • MIXED : • Metaraminol • ephedrine

  24. Pyrocatechin derivative – epinephrine & norepinephrine • Benzol derivative – levonordefrine • Phenol derivative – phenylephrine

  25. Conc. of clinically used VC Malamed

  26. LOCAL ANESTHETIC AGENTS

  27. PROCAINE • First synthetic injectable LA. • Ester type • Onset : 6 - 10 mins • Produces the most vasodilation, used to aid in breaking arteriospasm.

  28. LIDOCAINE • Most commonly used. • 1st amide LA in dentistry • By Lofgren, 1943 • Onset –rapid (2-3 mins) • Effective dental conc. -2% • Half life – 90 mins • Topical action – 5%

  29. MRD – 4 mg/kg or 7mg/kg with epinephrine In dental procedures – 2% lidocaine with1:100,000 epinephrine For hemostasis – 2% lidocaine with1:50,000 epinephrine

  30. BUPIVACAINE • Amide-type local anesthetic • Onset of action is slower than lidocaine and anesthesia is long acting. • Normally provides 2-4 hours of anesthesia • Can be extended in some cases by using solution with epinephrine to 7 hours

  31. 2 primary indication- • Lengthy procedures -90 mins (eg : full mouth reconstruction, implant surgery) • Management of surgery pain. • Rarely indicated in children.

  32. MEPIVACAINE • AMIDE • Introduced into dentistry as 2% soln. containing levonordefrin & 3%without vc • Slight vasodilation • Onset –rapid • Mepivacaine plain – most used LA in pediatric patients & in geriatric patients.

  33. PRILOCAINE • Amide • 40% less toxic • Orthotoluidine, induces the formation of methemoglobin – • Cyanosis • T/t – reversed within 15 mins with administration of 1-2 mg/kg body wt. of 1% methylene blue i.v. over a 5 min period • Effective conc. – 4%

  34. ARTICAINE • Amide type containing a thiophene group. • Synthesized in 1969 in Germany, • Effective conc. - 4 percent with 1:100,000 epinephrine. • Able to diffuse through hard & soft tissues more reliably than other LA. • The effect of numbness of soft tissues was longer lasting. IJPD

  35. TOPICAL ANESTHETICS

  36. TOPICAL ANESTHETICS • Topical anesthetic is effective on surface tissues (2-3 mm in depth) to reduce painful needle penetration of the oral mucosa. • A variety of agents are available in • Gel • Liquid • Ointment • Patch • Aerosol forms

  37. Higher conc. Facilitates diffusion of the drug through the mucous membrane. • BENZOCAINE :widely used since1903 • Odourless , white crystalline powder soluble in alcohol, fatty oils & dilute acids. • Absorbed very slowly from oral tssues & wounds. • 140 mg/ml

  38. COCAINE HYDROCHLORIDE • Highly soluble in water. • Onset – rapid ( 1 min ) • 2 to 10 % • Extreme abuse potential _ topical use in dentistry is not recommended. • DYCLONINE HYDROCHLORIDE • 0.5% • Onset – 10 mins • Duration – 1 hr. • EMLA • LIDOCAINE 2 forms : base- 5% HCl- 2%

  39. CONTRAINDICATIONS

  40. COMPLICATIONS • LOCAL • Needle breakage • Paraesthesia • Facial nerve paralysis • Trismus • Soft tissue injury • Hematoma • infection • Pain on injection • Burning on injection • Edema • Sloughing of tissues • Post anesthetic intra oral lesions

  41. SYSTEMIC • Overdose • Allergy : fever anaphylaxis angioedemaurticaria photosensitivity dermatitis • idiosyncrasy

  42. RECENT ADVANCES • EMLA • Lidocaine 2.5 % & prilocaine 2.5 % • Intact skin anesthesia, & is used primarily before painful procedures as venipuncture. • Routine use –circumcision ,leg ulcer debridement & in gynaecological procedures • 1 hr before

  43. Contraindicated <6mths possibility of prilocaine inducing methemoglobinemia.

  44. ROPIVACAINE– Long acting amide, has greater safety margin , less toxicity than bupivicaine. • pH ALTERATION- sodium bicarbonate is being added immediate to injection , which makes solution alkaline and thus increases its absorption into nerve. • Provides more rapid onset

  45. CENTBUCRIDINE- • Quinoline derivative • 5-8 times more potent • Significantly it does not affect the CNS, CVS adversely • Subarachnoid & extradural anesthesia(SuriYv et al : double blind study on centbucridine, indian J mer res 76:875-881 , 1982) • Intravenous regional anesthesia & intaocular surgery.

  46. HYALURONIDASE- Breaks down intercellular cement. Permits injected soln. to spread & penetrate tissues

More Related